FDA Approves Pediatric Use of Protalix Drug

Following the announcement of the most recent FDA approval at the end of last week, shares of Protalix rose by a combined 7.9%.

comments Print

Protalix Biotherapeutics has received expanded permission from the U.S. Food and Drug Administration to market its medication for...